TWD 10.4
(15.56%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -118.93 Million TWD | 10.77% |
2022 | -133.29 Million TWD | 13.58% |
2021 | -154.24 Million TWD | -62.01% |
2020 | -95.2 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -179.74 Million TWD | -51.12% |
2023 FY | -118.93 Million TWD | 10.77% |
2023 Q2 | -27.86 Million TWD | 79.1% |
2023 Q4 | -118.93 Million TWD | -326.88% |
2022 Q4 | -133.29 Million TWD | 0.0% |
2022 FY | -133.29 Million TWD | 13.58% |
2021 FY | -154.24 Million TWD | -62.01% |
2020 FY | -95.2 Million TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 54.977% |
Level Biotechnology Inc. | -453.9 Million TWD | 73.797% |
Sagittarius Life Science Corp | -120.57 Million TWD | 1.354% |
NeoCore Technology Co., Ltd. | -196.39 Million TWD | 39.44% |
GeneReach Biotechnology Corp. | 40.26 Million TWD | 395.381% |
Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 488.966% |
Visgeneer Inc. | 31.28 Million TWD | 480.188% |
Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 82.525% |
G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 11.407% |
Neith Corporation | -150.31 Million TWD | 20.872% |
TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -106.282% |
Enimmune corporation | -314.15 Million TWD | 62.141% |
TaiRx, Inc. | -147.86 Million TWD | 19.565% |
EirGenix Inc. | -4.58 Billion TWD | 97.408% |
BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -40.318% |
Sunny Pharmtech Inc. | 120.87 Million TWD | 198.401% |
Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -84.913% |
BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 62.53% |
Feng Chi Biotech Corp. | -19.81 Million TWD | -500.303% |
Lukas Biomedical Inc. | 50.75 Million TWD | 334.338% |
RBC Bioscience Corporation | 422.18 Million TWD | 128.172% |
BiOptic Inc. | 12.59 Million TWD | 1044.552% |
Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -54.377% |
Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -17.196% |
Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 27.993% |
Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 137.773% |
Mycenax Biotech Inc. | 207 Million TWD | 157.455% |
Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 119.136% |
Bio Preventive Medicine Corp. | 31.8 Million TWD | 473.913% |
TaiMed Biologics Inc. | 499.84 Million TWD | 123.795% |
GlycoNex Incorporation | -148.56 Million TWD | 19.943% |
Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 186.19% |
SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 54.704% |
Lin BioScience, Inc. | -3.21 Billion TWD | 96.304% |
BRIM Biotechnology, Inc. | -944.4 Million TWD | 87.406% |
VBI | -25.31 Million TWD | -369.814% |
CHO Pharma, Inc. | -203.79 Million TWD | 41.638% |
NaviFUS Corp. | -123.12 Million TWD | 3.404% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 260.616% |
Sinew Pharma Inc. | -160.34 Million TWD | 25.824% |
Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 50.83% |
Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 64.746% |
Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 71.176% |
AP Biosciences Inc | -196.52 Million TWD | 39.48% |
Medigen Biotechnology Corp. | 688.73 Million TWD | 117.269% |
3D Global Biotech Inc. | -11.43 Million TWD | -939.941% |
Pharmosa Biopharm Inc. | -829.69 Million TWD | 85.665% |
Intech Biopharm Corporation | 1.35 Billion TWD | 108.763% |
Oneness Biotech Co., Ltd. | -414.87 Million TWD | 71.332% |
Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 43.184% |
TWi Biotechnology, Inc. | -143.86 Million TWD | 17.326% |
Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 64.017% |
TCI GENE Inc. | -689.25 Million TWD | 82.744% |
Senhwa Biosciences, Inc. | -1.3 Billion TWD | 90.915% |
Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 680.667% |
NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -16.755% |
PharmaEngine, Inc. | -860.8 Million TWD | 86.183% |
Savior Lifetec Corporation | -812.54 Million TWD | 85.362% |
TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 60.35% |
OBI Pharma, Inc. | -398.22 Million TWD | 70.133% |
Meribank Biotech Co., Ltd | -365.41 Million TWD | 67.452% |
Acepodia, Inc. | -6.02 Billion TWD | 98.024% |
Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 96.504% |